Kazia Therapeutics | Evaluate

February 07, 2022

Evotec's loss is disappointing, but there is more in the locker

January 05, 2021

Hope versus experience in glioblastoma

Development of new drugs for this hard-to-treat brain cancer is a slow and incremental process.

August 30, 2018

Seeking alpha in PI3K inhibition

Novartis hails the most advanced alpha-directed PI3K inhibitor after success in breast cancer, but it’s not the only one.

December 06, 2016

Ash – Early data for next generation of Imbruvica’s challengers

November 04, 2016

Snippet roundup: Infinity sells duvelisib, Celldex buys Kolltan and Zimmer Biomet has supply woes

January 07, 2011

Comeback stories drive small cap risers in 2010